Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | yes | yes: 6 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 12 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 2 |
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0008541 | proteasome regulatory particle, lid subcomplex | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0005838 | proteasome regulatory particle | 2 | 10 |
Related structures:
AlphaFold database: Q4Q5G2
Term | Name | Level | Count |
---|---|---|---|
GO:0006508 | proteolysis | 4 | 12 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009057 | macromolecule catabolic process | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0010498 | proteasomal protein catabolic process | 5 | 2 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0019941 | modification-dependent protein catabolic process | 6 | 2 |
GO:0030163 | protein catabolic process | 4 | 2 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043632 | modification-dependent macromolecule catabolic process | 5 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 2 |
GO:0051603 | proteolysis involved in protein catabolic process | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:1901565 | organonitrogen compound catabolic process | 4 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.453 |
CLV_NRD_NRD_1 | 171 | 173 | PF00675 | 0.375 |
CLV_NRD_NRD_1 | 42 | 44 | PF00675 | 0.487 |
CLV_PCSK_KEX2_1 | 229 | 231 | PF00082 | 0.260 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.486 |
CLV_PCSK_PC1ET2_1 | 229 | 231 | PF00082 | 0.342 |
CLV_PCSK_PC1ET2_1 | 41 | 43 | PF00082 | 0.486 |
CLV_PCSK_SKI1_1 | 167 | 171 | PF00082 | 0.324 |
CLV_PCSK_SKI1_1 | 19 | 23 | PF00082 | 0.482 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 115 | 124 | PF00134 | 0.471 |
DOC_MAPK_gen_1 | 41 | 47 | PF00069 | 0.422 |
DOC_MAPK_MEF2A_6 | 68 | 75 | PF00069 | 0.494 |
DOC_MAPK_NFAT4_5 | 68 | 76 | PF00069 | 0.493 |
DOC_PP1_RVXF_1 | 41 | 48 | PF00149 | 0.507 |
DOC_PP2B_LxvP_1 | 206 | 209 | PF13499 | 0.575 |
DOC_PP4_FxxP_1 | 50 | 53 | PF00568 | 0.451 |
DOC_SPAK_OSR1_1 | 151 | 155 | PF12202 | 0.482 |
DOC_WW_Pin1_4 | 106 | 111 | PF00397 | 0.447 |
LIG_Actin_WH2_2 | 7 | 24 | PF00022 | 0.483 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.539 |
LIG_FHA_1 | 237 | 243 | PF00498 | 0.630 |
LIG_FHA_2 | 188 | 194 | PF00498 | 0.575 |
LIG_FHA_2 | 242 | 248 | PF00498 | 0.474 |
LIG_FHA_2 | 57 | 63 | PF00498 | 0.485 |
LIG_LIR_Apic_2 | 49 | 53 | PF02991 | 0.443 |
LIG_LIR_Gen_1 | 109 | 120 | PF02991 | 0.418 |
LIG_LIR_Gen_1 | 146 | 156 | PF02991 | 0.519 |
LIG_LIR_Gen_1 | 162 | 169 | PF02991 | 0.501 |
LIG_LIR_Gen_1 | 69 | 77 | PF02991 | 0.481 |
LIG_LIR_Gen_1 | 88 | 98 | PF02991 | 0.361 |
LIG_LIR_Nem_3 | 109 | 115 | PF02991 | 0.446 |
LIG_LIR_Nem_3 | 146 | 152 | PF02991 | 0.519 |
LIG_LIR_Nem_3 | 162 | 168 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 201 | 206 | PF02991 | 0.498 |
LIG_LIR_Nem_3 | 69 | 73 | PF02991 | 0.470 |
LIG_LIR_Nem_3 | 86 | 90 | PF02991 | 0.379 |
LIG_LRP6_Inhibitor_1 | 116 | 122 | PF00058 | 0.375 |
LIG_NRBOX | 119 | 125 | PF00104 | 0.471 |
LIG_Pex14_2 | 87 | 91 | PF04695 | 0.368 |
LIG_SH2_CRK | 165 | 169 | PF00017 | 0.485 |
LIG_SH2_CRK | 203 | 207 | PF00017 | 0.496 |
LIG_SH2_GRB2like | 90 | 93 | PF00017 | 0.371 |
LIG_SH2_NCK_1 | 98 | 102 | PF00017 | 0.449 |
LIG_SH2_SRC | 180 | 183 | PF00017 | 0.482 |
LIG_SH2_STAT3 | 90 | 93 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 112 | 115 | PF00017 | 0.540 |
LIG_SH2_STAT5 | 149 | 152 | PF00017 | 0.501 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.513 |
LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 70 | 73 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 90 | 93 | PF00017 | 0.358 |
LIG_SH3_3 | 104 | 110 | PF00018 | 0.482 |
LIG_SUMO_SIM_par_1 | 213 | 220 | PF11976 | 0.498 |
LIG_TYR_ITIM | 96 | 101 | PF00017 | 0.463 |
LIG_UBA3_1 | 36 | 41 | PF00899 | 0.418 |
LIG_WRC_WIRS_1 | 47 | 52 | PF05994 | 0.422 |
LIG_WRC_WIRS_1 | 84 | 89 | PF05994 | 0.408 |
MOD_CK2_1 | 131 | 137 | PF00069 | 0.471 |
MOD_CK2_1 | 56 | 62 | PF00069 | 0.504 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.641 |
MOD_GlcNHglycan | 234 | 237 | PF01048 | 0.316 |
MOD_GlcNHglycan | 77 | 80 | PF01048 | 0.367 |
MOD_GSK3_1 | 232 | 239 | PF00069 | 0.508 |
MOD_GSK3_1 | 54 | 61 | PF00069 | 0.537 |
MOD_NEK2_1 | 124 | 129 | PF00069 | 0.538 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.471 |
MOD_NEK2_1 | 168 | 173 | PF00069 | 0.471 |
MOD_NEK2_1 | 187 | 192 | PF00069 | 0.472 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.582 |
MOD_PK_1 | 204 | 210 | PF00069 | 0.501 |
MOD_Plk_1 | 187 | 193 | PF00069 | 0.491 |
MOD_Plk_1 | 246 | 252 | PF00069 | 0.657 |
MOD_Plk_1 | 5 | 11 | PF00069 | 0.577 |
MOD_Plk_1 | 62 | 68 | PF00069 | 0.451 |
MOD_Plk_2-3 | 131 | 137 | PF00069 | 0.538 |
MOD_Plk_2-3 | 83 | 89 | PF00069 | 0.409 |
MOD_Plk_4 | 46 | 52 | PF00069 | 0.453 |
MOD_ProDKin_1 | 106 | 112 | PF00069 | 0.440 |
MOD_SUMO_for_1 | 228 | 231 | PF00179 | 0.553 |
MOD_SUMO_rev_2 | 16 | 21 | PF00179 | 0.563 |
MOD_SUMO_rev_2 | 218 | 223 | PF00179 | 0.538 |
TRG_DiLeu_BaLyEn_6 | 119 | 124 | PF01217 | 0.471 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.408 |
TRG_ENDOCYTIC_2 | 149 | 152 | PF00928 | 0.501 |
TRG_ENDOCYTIC_2 | 165 | 168 | PF00928 | 0.523 |
TRG_ENDOCYTIC_2 | 180 | 183 | PF00928 | 0.505 |
TRG_ENDOCYTIC_2 | 203 | 206 | PF00928 | 0.501 |
TRG_ENDOCYTIC_2 | 70 | 73 | PF00928 | 0.481 |
TRG_ENDOCYTIC_2 | 98 | 101 | PF00928 | 0.416 |
TRG_ER_diArg_1 | 42 | 44 | PF00400 | 0.544 |
TRG_NLS_MonoExtC_3 | 171 | 176 | PF00514 | 0.575 |
TRG_Pf-PMV_PEXEL_1 | 12 | 16 | PF00026 | 0.467 |
TRG_Pf-PMV_PEXEL_1 | 158 | 162 | PF00026 | 0.271 |
TRG_Pf-PMV_PEXEL_1 | 213 | 218 | PF00026 | 0.341 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I4A9 | Leptomonas seymouri | 83% | 100% |
A0A0S4J927 | Bodo saltans | 51% | 79% |
A0A1X0NUT6 | Trypanosomatidae | 59% | 100% |
A0A3R7M9M8 | Trypanosoma rangeli | 62% | 100% |
A0A3S7X5G0 | Leishmania donovani | 98% | 100% |
A4HKA7 | Leishmania braziliensis | 90% | 100% |
A4I7T7 | Leishmania infantum | 98% | 100% |
D0A9Z7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 100% |
E9B2P5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
P02889 | Dictyostelium discoideum | 35% | 100% |
P32496 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 30% | 100% |
P48556 | Homo sapiens | 37% | 78% |
P50524 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 27% | 100% |
Q23449 | Caenorhabditis elegans | 34% | 100% |
Q3SYT7 | Bos taurus | 37% | 95% |
Q5RE15 | Pongo abelii | 37% | 95% |
Q9CX56 | Mus musculus | 37% | 78% |
Q9SGW3 | Arabidopsis thaliana | 36% | 100% |
V5DHL8 | Trypanosoma cruzi | 62% | 100% |